{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:36:36Z","timestamp":1790613396494,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03331-9","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T05:25:47Z","timestamp":1677648347000},"page":"669-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization"],"prefix":"10.1007","volume":"80","author":[{"given":"Luigi","family":"di Filippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melin","family":"Uygur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Nannipieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Frara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"3331_CR1","unstructured":"A. Giustina, A.M. Formenti, Does hypovitaminosis D play a role in the high impact of COVID infection in Italy? Brit. Med. J. (2020). https:\/\/www.bmj.com\/content\/368\/bmj.m810\/rr-36"},{"issue":"4","key":"3331_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/er.2018-00126","volume":"40","author":"R Bouillon","year":"2019","unstructured":"R. Bouillon, C. Marcocci, G. Carmeliet et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 40(4), 1109\u20131151 (2019). https:\/\/doi.org\/10.1210\/er.2018-00126","journal-title":"Endocr. Rev."},{"issue":"5","key":"3331_CR3","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1530\/EJE-20-0665","volume":"183","author":"JP Bilezikian","year":"2020","unstructured":"J.P. Bilezikian, D. Bikle, M. Hewison et al. MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19. Eur. J. Endocrinol. 183(5), R133\u2013R147 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0665","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"3331_CR4","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/nu12072097","volume":"12","author":"N Charoenngam","year":"2020","unstructured":"N. Charoenngam, M.F. Holick, Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 12(7), 2097 (2020). https:\/\/doi.org\/10.3390\/nu12072097","journal-title":"Nutrients"},{"key":"3331_CR5","unstructured":"WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. https:\/\/covid19.who.int\/ (last cited: [09\/20\/2022])"},{"issue":"5","key":"3331_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/clinem\/dgab892","volume":"107","author":"HA Dissanayake","year":"2022","unstructured":"H.A. Dissanayake, N.L. de Silva, M. Sumanatilleke et al. Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis. J. Clin. Endocrinol. Metab. 107(5), 1484\u20131502 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgab892","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3331_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.18433\/jpps32518","volume":"25","author":"R Hopefl","year":"2022","unstructured":"R. Hopefl, M. Ben-Eltriki, S. Deb, Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies. J. Pharm. Pharm. Sci. 25, 124\u2013136 (2022). https:\/\/doi.org\/10.18433\/jpps32518","journal-title":"J. Pharm. Pharm. Sci."},{"key":"3331_CR8","doi-asserted-by":"publisher","first-page":"736665","DOI":"10.3389\/fpubh.2021.736665","volume":"9","author":"I Chiodini","year":"2021","unstructured":"I. Chiodini, D. Gatti, D. Soranna et al. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front. Public Health 9, 736665 (2021). https:\/\/doi.org\/10.3389\/fpubh.2021.736665","journal-title":"Front. Public Health"},{"key":"3331_CR9","doi-asserted-by":"publisher","first-page":"660420","DOI":"10.3389\/fnut.2021.660420","volume":"8","author":"MR Akbar","year":"2021","unstructured":"M.R. Akbar, A. Wibowo, R. Pranata, B. Setiabudiawan, Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis [published correction appears in Front Nutr. 2021 Sep 27;8:754539]. Front. Nutr. 8, 660420 (2021). https:\/\/doi.org\/10.3389\/fnut.2021.660420","journal-title":"Front. Nutr."},{"issue":"1","key":"3331_CR10","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1210\/clinem\/dgab599","volume":"107","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, A. Allora, M. Doga et al. Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity. J. Clin. Endocrinol. Metab. 107(1), e348\u2013e360 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgab599","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"3331_CR11","doi-asserted-by":"publisher","first-page":"e0239252","DOI":"10.1371\/journal.pone.0239252","volume":"15","author":"HW Kaufman","year":"2020","unstructured":"H.W. Kaufman, J.K. Niles, M.H. Kroll, C. Bi, M.F. Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15(9), e0239252 (2020). https:\/\/doi.org\/10.1371\/journal.pone.0239252","journal-title":"PLoS ONE"},{"issue":"4","key":"3331_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.eprac.2021.02.013","volume":"27","author":"N Charoenngam","year":"2021","unstructured":"N. Charoenngam, A. Shirvani, N. Reddy, D.M. Vodopivec, C.M. Apovian, M.F. Holick, Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19. Endocr. Pr. 27(4), 271\u2013278 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2021.02.013","journal-title":"Endocr. Pr."},{"key":"3331_CR13","doi-asserted-by":"publisher","first-page":"934258","DOI":"10.3389\/fnut.2022.934258","volume":"9","author":"L Bogliolo","year":"2022","unstructured":"L. Bogliolo, E. Cereda, C. Klersy et al. Vitamin D 25OH deficiency and mortality in moderate to severe COVID-19: a multi-center prospective observational study. Front. Nutr. 9, 934258 (2022). https:\/\/doi.org\/10.3389\/fnut.2022.934258","journal-title":"Front. Nutr."},{"issue":"1","key":"3331_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4102\/sajid.v37i1.359","volume":"37","author":"S Kalichuran","year":"2022","unstructured":"S. Kalichuran, S.A. van Blydenstein, M. Venter, S. Omar, Vitamin D status and COVID-19 severity. S Afr. J. Infect. Dis. 37(1), 359 (2022). https:\/\/doi.org\/10.4102\/sajid.v37i1.359","journal-title":"S Afr. J. Infect. Dis."},{"issue":"Suppl 1","key":"3331_CR15","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.4162\/nrp.2021.15.S1.S32","volume":"15","author":"I Parra-Ortega","year":"2021","unstructured":"I. Parra-Ortega, D.G. Alcara-Ram\u00edrez, A.A. Ronzon-Ronzon et al. 25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City. Nutr. Res Pr. 15(Suppl 1), S32\u2013S40 (2021). https:\/\/doi.org\/10.4162\/nrp.2021.15.S1.S32","journal-title":"Nutr. Res Pr."},{"key":"3331_CR16","doi-asserted-by":"publisher","first-page":"111408","DOI":"10.1016\/j.nut.2021.111408","volume":"91-92","author":"V Bianconi","year":"2021","unstructured":"V. Bianconi, M.R. Mannarino, F. Figorilli et al. Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19. Nutrition 91-92, 111408 (2021). https:\/\/doi.org\/10.1016\/j.nut.2021.111408","journal-title":"Nutrition"},{"issue":"1","key":"3331_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06281-7","volume":"21","author":"I Campi","year":"2021","unstructured":"I. Campi, L. Gennari, D. Merlotti et al. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect. Dis. 21(1), 566 (2021). https:\/\/doi.org\/10.1186\/s12879-021-06281-7","journal-title":"BMC Infect. Dis."},{"key":"3331_CR18","doi-asserted-by":"publisher","first-page":"E1652","DOI":"10.3390\/cells9071652","volume":"9","author":"R Amraei","year":"2020","unstructured":"R. Amraei, N. Rahimi, COVID-19, renin-angiotensin system and endothelial dysfunction. Cells 9, E1652 (2020). https:\/\/doi.org\/10.3390\/cells9071652","journal-title":"Cells"},{"issue":"2","key":"3331_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"M. Hoffmann, H. Kleine-Weber, S. Schroeder et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2), 271\u2013280.e8 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"2","key":"3331_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"I. Hamming, W. Timens, M.L. Bulthuis, A.T. Lely, G. Navis, H. van Goor, Tissue distribution of ACE-2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203(2), 631\u2013637 (2004). https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J. Pathol."},{"issue":"3","key":"3331_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"S. Frara, A. Allora, L. Castellino, L. di Filippo, P. Loli, A. Giustina, COVID-19 and the pituitary. Pituitary 24(3), 465\u2013481 (2021). https:\/\/doi.org\/10.1007\/s11102-021-01148-1","journal-title":"Pituitary"},{"key":"3331_CR22","doi-asserted-by":"publisher","first-page":"789180","DOI":"10.3389\/fcimb.2021.789180","volume":"11","author":"J Wang","year":"2022","unstructured":"J. Wang, H. Zhao, Y. An, ACE-2 Shedding and the Role in COVID-19. Front Cell Infect. Microbiol. 11, 789180 (2022). https:\/\/doi.org\/10.3389\/fcimb.2021.789180","journal-title":"Front Cell Infect. Microbiol."},{"key":"3331_CR23","doi-asserted-by":"publisher","first-page":"790513","DOI":"10.3389\/fmed.2021.790513","volume":"8","author":"AS Dusso","year":"2021","unstructured":"A.S. Dusso, K.T. Bauerle, C. Bernal-Mizrachi, Non-classical Vitamin D Actions for Renal Protection. Front Med (Lausanne) 8, 790513 (2021). https:\/\/doi.org\/10.3389\/fmed.2021.790513","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"3331_CR24","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1002\/jmv.27075","volume":"93","author":"B Getachew","year":"2021","unstructured":"B. Getachew, Y. Tizabi, Vitamin D and COVID-19: Role of ACE-2, age, gender, and ethnicity. J. Med Virol. 93(9), 5285\u20135294 (2021). https:\/\/doi.org\/10.1002\/jmv.27075","journal-title":"J. Med Virol."},{"issue":"5","key":"3331_CR25","doi-asserted-by":"publisher","first-page":"e2119","DOI":"10.1002\/rmv.2119","volume":"30","author":"A Malek Mahdavi","year":"2020","unstructured":"A. Malek Mahdavi, A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. Rev. Med Virol. 30(5), e2119 (2020). https:\/\/doi.org\/10.1002\/rmv.2119","journal-title":"Rev. Med Virol."},{"key":"3331_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jsbmb.2012.11.017","volume":"136","author":"DA Jolliffe","year":"2013","unstructured":"D.A. Jolliffe, C.J. Griffiths, A.R. Martineau, Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J. Steroid Biochem Mol. Biol. 136, 321\u2013329 (2013). https:\/\/doi.org\/10.1016\/j.jsbmb.2012.11.017","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"4","key":"3331_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","volume":"22","author":"JP Bilezikian","year":"2021","unstructured":"J.P. Bilezikian, A.M. Formenti, R.A. Adler et al. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all. Rev. Endocr. Metab. Disord. 22(4), 1201\u20131218 (2021). https:\/\/doi.org\/10.1007\/s11154-021-09693-7","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"12","key":"3331_CR28","doi-asserted-by":"publisher","first-page":"e10417","DOI":"10.1002\/jbm4.10417","volume":"4","author":"A Giustina","year":"2020","unstructured":"A. Giustina, R. Bouillon, N. Binkley et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 4(12), e10417 (2020). https:\/\/doi.org\/10.1002\/jbm4.10417","journal-title":"JBMR Plus."},{"issue":"7","key":"3331_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jclinpath-2012-201301","volume":"66","author":"JL Waldron","year":"2013","unstructured":"J.L. Waldron, H.L. Ashby, M.P. Cornes et al. Vitamin D: a negative acute phase reactant. J. Clin. Pathol. 66(7), 620\u2013622 (2013). https:\/\/doi.org\/10.1136\/jclinpath-2012-201301","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"3331_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","volume":"2","author":"P Autier","year":"2014","unstructured":"P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2(1), 76\u201389 (2014). https:\/\/doi.org\/10.1016\/S2213-8587(13)70165-7","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"3331_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/cc9341","volume":"14","author":"A Krishnan","year":"2010","unstructured":"A. Krishnan, J. Ochola, J. Mundy et al. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit. Care 14(6), R216 (2010). https:\/\/doi.org\/10.1186\/cc9341","journal-title":"Crit. Care"},{"issue":"7","key":"3331_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/00003246-199207000-00007","volume":"20","author":"JA Louw","year":"1992","unstructured":"J.A. Louw, A. Werbeck, M.E. Louw, T.J. Kotze, R. Cooper, D. Labadarios, Blood vitamin concentrations during the acute-phase response. Crit. Care Med. 20(7), 934\u2013941 (1992). https:\/\/doi.org\/10.1097\/00003246-199207000-00007","journal-title":"Crit. Care Med."},{"issue":"4","key":"3331_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/07435800.2011.554937","volume":"36","author":"UC Bang","year":"2011","unstructured":"U.C. Bang, S. Novovic, A.M. Andersen, M. Fenger, M.B. Hansen, J.E. Jensen, Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr. Res. 36(4), 135\u2013141 (2011). https:\/\/doi.org\/10.3109\/07435800.2011.554937","journal-title":"Endocr. Res."},{"issue":"2","key":"3331_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.nutres.2014.12.008","volume":"35","author":"MC Silva","year":"2015","unstructured":"M.C. Silva, T.W. Furlanetto, Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr. Res. 35(2), 91\u201396 (2015). https:\/\/doi.org\/10.1016\/j.nutres.2014.12.008","journal-title":"Nutr. Res."},{"issue":"1","key":"3331_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","volume":"68","author":"A Giustina","year":"2020","unstructured":"A. Giustina, COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1), 2\u20135 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02294-5","journal-title":"Endocrine"},{"key":"3331_CR36","doi-asserted-by":"publisher","first-page":"154434","DOI":"10.1016\/j.metabol.2020.154434","volume":"115","author":"J Smolders","year":"2021","unstructured":"J. Smolders, J. van den Ouweland, C. Geven, P. Pickkers, M. Kox, Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism 115, 154434 (2021). https:\/\/doi.org\/10.1016\/j.metabol.2020.154434","journal-title":"Metabolism"},{"issue":"13","key":"3331_CR37","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3390\/nu14132757","volume":"14","author":"D Gupta","year":"2022","unstructured":"D. Gupta, S. Menon, M.H. Criqui, B.K. Sun, Temporal Association of Reduced Serum Vitamin D with COVID-19 Infection: Two Single-Institution Case-Control Studies. Nutrients 14(13), 2757 (2022). https:\/\/doi.org\/10.3390\/nu14132757","journal-title":"Nutrients"},{"key":"3331_CR38","doi-asserted-by":"publisher","unstructured":"J.P. Bilezikian, N. Binkley, H.F. De Luca et al. Consensus and Controversial Aspects of Vitamin D and COVID-19. J. Clin. Endocrinol. Metab. dgac719 (2022) https:\/\/doi.org\/10.1210\/clinem\/dgac719","DOI":"10.1210\/clinem\/dgac719"},{"key":"3331_CR39","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","volume":"370","author":"A Agarwal","year":"2020","unstructured":"A. Agarwal, B. Rochwerg, F. Lamontagne, et al., A living WHO guideline on drugs for covid-19 [published correction appears in BMJ]. BMJ 370, m3379 (2020). https:\/\/doi.org\/10.1136\/bmj.m3379","journal-title":"BMJ"},{"key":"3331_CR40","unstructured":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 854, 1\u2013452 (1995)"},{"issue":"10","key":"3331_CR41","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/bcp.13652","volume":"84","author":"CT Sempos","year":"2018","unstructured":"C.T. Sempos, A.C. Heijboer, D.D. Bikle et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br. J. Clin. Pharm. 84(10), 2194\u20132207 (2018). https:\/\/doi.org\/10.1111\/bcp.13652","journal-title":"Br. J. Clin. Pharm."},{"key":"3331_CR42","unstructured":"WHO World Health Organization. COVID-19 Clinical management Living guidance, (2021). WHO reference number: WHO\/2019-nCoV\/clinical\/2021.1"},{"issue":"4","key":"3331_CR43","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/S2665-9913(21)00012-6","volume":"3","author":"G Cavalli","year":"2021","unstructured":"G. Cavalli, A. Larcher, A. Tomelleri et al. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 3(4), e253\u2013e261 (2021). https:\/\/doi.org\/10.1016\/S2665-9913(21)00012-6","journal-title":"Lancet Rheumatol."},{"issue":"3 Pt 1","key":"3331_CR44","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","volume":"149","author":"GR Bernard","year":"1994","unstructured":"G.R. Bernard, A. Artigas, K.L. Brigham et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149(3 Pt 1), 818\u2013824 (1994). https:\/\/doi.org\/10.1164\/ajrccm.149.3.7509706","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"23","key":"3331_CR45","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, V.M. Ranieri, G.D. Rubenfeld et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23), 2526\u20132533 (2012). https:\/\/doi.org\/10.1001\/jama.2012.5669","journal-title":"JAMA"},{"issue":"6","key":"3331_CR46","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/er.2008-0004","volume":"29","author":"R Bouillon","year":"2008","unstructured":"R. Bouillon, G. Carmeliet, L. Verlinden et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29(6), 726\u2013776 (2008). https:\/\/doi.org\/10.1210\/er.2008-0004","journal-title":"Endocr. Rev."},{"key":"3331_CR47","doi-asserted-by":"publisher","first-page":"107686","DOI":"10.1016\/j.intimp.2021.107686","volume":"97","author":"M Shah Alam","year":"2021","unstructured":"M. Shah Alam, D.M. Czajkowsky, M. Aminul Islam, M. Ataur Rahman, The role of vitamin D in reducing SARS-CoV-2 infection: An update. Int. Immunopharmacol. 97, 107686 (2021). https:\/\/doi.org\/10.1016\/j.intimp.2021.107686","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"3331_CR48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/14787210.2022.2035217","volume":"20","author":"SR Varikasuvu","year":"2022","unstructured":"S.R. Varikasuvu, B. Thangappazham, A. Vykunta et al. COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev. Anti Infect. Ther. 20(6), 907\u2013913 (2022). https:\/\/doi.org\/10.1080\/14787210.2022.2035217","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"3331_CR49","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/nu14102134","volume":"14","author":"B Hosseini","year":"2022","unstructured":"B. Hosseini, A. El Abd, F.M. Ducharme, Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 14(10), 2134 (2022). https:\/\/doi.org\/10.3390\/nu14102134","journal-title":"Nutrients"},{"key":"3331_CR50","doi-asserted-by":"publisher","first-page":"105751","DOI":"10.1016\/j.jsbmb.2020.105751","volume":"203","author":"M Entrenas Castillo","year":"2020","unstructured":"M. Entrenas Castillo, L.M. Entrenas Costa, J.M. Vaquero Barrios et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study\u201d. J. Steroid Biochem Mol. Biol. 203, 105751 (2020). https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105751","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"12","key":"3331_CR51","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.eprac.2021.09.016","volume":"27","author":"Z Maghbooli","year":"2021","unstructured":"Z. Maghbooli, M.A. Sahraian, S. Jamalimoghadamsiahkali et al. Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial. Endocr. Pract. 27(12), 1242\u20131251 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2021.09.016","journal-title":"Endocr. Pract."},{"key":"3331_CR52","doi-asserted-by":"publisher","first-page":"e071230","DOI":"10.1136\/bmj-2022-071230","volume":"378","author":"DA Jolliffe","year":"2022","unstructured":"D.A. Jolliffe, H. Holt, M. Greenig et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ 378, e071230 (2022). https:\/\/doi.org\/10.1136\/bmj-2022-071230","journal-title":"BMJ"},{"issue":"3","key":"3331_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/ajcp\/aqaa252","volume":"155","author":"D De Smet","year":"2021","unstructured":"D. De Smet, K. De Smet, P. Herroelen, S. Gryspeerdt, G.A. Martens, Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality. Am. J. Clin. Pathol. 155(3), 381\u2013388 (2021). https:\/\/doi.org\/10.1093\/ajcp\/aqaa252","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"3331_CR54","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s11606-021-07170-0","volume":"37","author":"KH Seal","year":"2022","unstructured":"K.H. Seal, D. Bertenthal, E. Carey, C. Grunfeld, D.D. Bikle, C.M. Lu, Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality. J. Gen. Intern Med. 37(4), 853\u2013861 (2022). https:\/\/doi.org\/10.1007\/s11606-021-07170-0","journal-title":"J. Gen. Intern Med"},{"key":"3331_CR55","doi-asserted-by":"publisher","first-page":"813485","DOI":"10.3389\/fnut.2022.813485","volume":"9","author":"PE Vanegas-Cedillo","year":"2022","unstructured":"P.E. Vanegas-Cedillo, O.Y. Bello-Chavolla, N. Ram\u00edrez-Pedraza et al. Serum Vitamin D Levels Are Associated With Increased COVID-19 Severity and Mortality Independent of Whole-Body and Visceral Adiposity. Front Nutr. 9, 813485 (2022). https:\/\/doi.org\/10.3389\/fnut.2022.813485","journal-title":"Front Nutr."},{"key":"3331_CR56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clnesp.2022.05.027","volume":"50","author":"FF Neves","year":"2022","unstructured":"F.F. Neves, H. Pott-Junior, S. de Sousa Santos et al. Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19. Clin. Nutr. ESPEN 50, 322\u2013325 (2022). https:\/\/doi.org\/10.1016\/j.clnesp.2022.05.027","journal-title":"Clin. Nutr. ESPEN"},{"issue":"3","key":"3331_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cen.14540","volume":"96","author":"Z Wang","year":"2022","unstructured":"Z. Wang, A. Joshi, K. Leopold et al. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis. Clin. Endocrinol. 96(3), 281\u2013287 (2022). https:\/\/doi.org\/10.1111\/cen.14540","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"3331_CR58","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1080\/10408398.2020.1841090","volume":"62","author":"M Pereira","year":"2022","unstructured":"M. Pereira, A. Dantas Damascena, L.M. Galv\u00e3o Azevedo, T. de Almeida Oliveira, J. da Mota Santana, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 62(5), 1308\u20131316 (2022). https:\/\/doi.org\/10.1080\/10408398.2020.1841090","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"6","key":"3331_CR59","doi-asserted-by":"publisher","first-page":"e1003605","DOI":"10.1371\/journal.pmed.1003605","volume":"18","author":"G Butler-Laporte","year":"2021","unstructured":"G. Butler-Laporte, T. Nakanishi, V. Mooser et al. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study. PLoS Med. 18(6), e1003605 (2021). https:\/\/doi.org\/10.1371\/journal.pmed.1003605","journal-title":"PLoS Med."},{"key":"3331_CR60","doi-asserted-by":"publisher","first-page":"154753","DOI":"10.1016\/j.metabol.2021.154753","volume":"119","author":"A Bassatne","year":"2021","unstructured":"A. Bassatne, M. Basbous, M. Chakhtoura, O. El Zein, M. Rahme, G. El-Hajj Fuleihan, The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis. Metabolism 119, 154753 (2021). https:\/\/doi.org\/10.1016\/j.metabol.2021.154753","journal-title":"Metabolism"},{"issue":"1","key":"3331_CR61","doi-asserted-by":"publisher","first-page":"e10447","DOI":"10.1002\/jbm4.10447","volume":"5","author":"S Minisola","year":"2020","unstructured":"S. Minisola, L. Colangelo, J. Pepe, D. Diacinti, C. Cipriani, S.D. Rao, Osteomalacia and Vitamin D Status: A Clinical Update 2020. JBMR . 5(1), e10447 (2020). https:\/\/doi.org\/10.1002\/jbm4.10447","journal-title":"JBMR ."},{"issue":"2","key":"3331_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-021-02734-w","volume":"72","author":"M Puig-Domingo","year":"2021","unstructured":"M. Puig-Domingo, M. Marazuela, B.O. Yildiz, A. Giustina, COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2), 301\u2013316 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02734-w","journal-title":"Endocrine"},{"issue":"4","key":"3331_CR63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11154-020-09569-2","volume":"21","author":"M Marazuela","year":"2020","unstructured":"M. Marazuela, A. Giustina, M. Puig-Domingo, Endocrine and metabolic aspects of the COVID-19 pandemic [published correction appears in Rev Endocr Metab Disord. 2021 Mar;22(1):145]. Rev. Endocr. Metab. Disord. 21(4), 495\u2013507 (2020). https:\/\/doi.org\/10.1007\/s11154-020-09569-2","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"3331_CR64","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","volume":"68","author":"M Puig-Domingo","year":"2020","unstructured":"M. Puig-Domingo, M. Marazuela, A. Giustina, COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1), 2\u20135 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02294-5","journal-title":"Endocrine"},{"key":"3331_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clnesp.2021.04.001","volume":"43","author":"R Pranata","year":"2021","unstructured":"R. Pranata, M.A. Lim, I. Huang et al. Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. Clin. Nutr. ESPEN 43, 163\u2013168 (2021). https:\/\/doi.org\/10.1016\/j.clnesp.2021.04.001","journal-title":"Clin. Nutr. ESPEN"},{"issue":"12","key":"3331_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.tem.2020.09.003","volume":"31","author":"ML Brandi","year":"2020","unstructured":"M.L. Brandi, A. Giustina, Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality. Trends Endocrinol. Metab. 31(12), 918\u2013927 (2020). https:\/\/doi.org\/10.1016\/j.tem.2020.09.003","journal-title":"Trends Endocrinol. Metab."},{"key":"3331_CR67","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","volume":"16","author":"J Xu","year":"2017","unstructured":"J. Xu, J. Yang, J. Chen, Q. Luo, Q. Zhang, H. Zhang, Vitamin D alleviates lipopolysaccharide\u2010induced acute lung injury via regulation of the renin\u2010angiotensin system. Mol. Med. Rep. 16, 7432\u20137438 (2017)","journal-title":"Mol. Med. Rep."},{"key":"3331_CR68","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.injury.2016.09.025","volume":"47","author":"J Yang","year":"2016","unstructured":"J. Yang, H. Zhang, Z. Xu, Effect of vitamin D on ACE-2 and vitamin d receptor expression in rats with LPS\u2010induced acute lung. Injury 47, 2816\u20132821 (2016)","journal-title":"Injury"},{"key":"3331_CR69","doi-asserted-by":"publisher","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","volume":"310","author":"M Riera","year":"2016","unstructured":"M. Riera, L. Anguiano, S. Clotet et al. Paricalcitol modulates ACE-2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am. J. Physiol. Ren. Physiol. 310, F534\u2013F546 (2016)","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1-5","key":"3331_CR70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jsbmb.2004.03.004","volume":"89-90","author":"YC Li","year":"2004","unstructured":"Y.C. Li, G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, J. Kong, Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89-90(1-5), 387\u2013392 (2004). https:\/\/doi.org\/10.1016\/j.jsbmb.2004.03.004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"3331_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI15219","volume":"110","author":"YC Li","year":"2002","unstructured":"Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, L.P. Cao, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Investig. 110(2), 229\u2013238 (2002). https:\/\/doi.org\/10.1172\/JCI15219","journal-title":"J. Clin. Investig."},{"issue":"17-18","key":"3331_CR72","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","volume":"411","author":"A Tomaschitz","year":"2010","unstructured":"A. Tomaschitz, S. Pilz, E. Ritz et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin. Chim. Acta 411(17-18), 1354\u20131360 (2010). https:\/\/doi.org\/10.1016\/j.cca.2010.05.037","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"3331_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2213","volume":"31","author":"MM Rahman","year":"2021","unstructured":"M.M. Rahman, M. Hasan, A. Ahmed, Potential detrimental role of soluble ACE-2 in severe COVID-19 comorbid patients. Rev. Med. Virol. 31(5), 1\u201312 (2021). https:\/\/doi.org\/10.1002\/rmv.2213","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"3331_CR74","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/cells10071814","volume":"10","author":"T Karthika","year":"2021","unstructured":"T. Karthika, J. Joseph, V.R.A. Das, N. Nair, P. Charulekha, M.D. Roji et al. SARS-CoV-2 cellular entry is independent of the ACE-2 cytoplasmic domain signaling. Cells 10(7), 1814 (2021). https:\/\/doi.org\/10.3390\/cells10071814","journal-title":"Cells"},{"issue":"8","key":"3331_CR75","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","volume":"184","author":"ML Yeung","year":"2021","unstructured":"M.L. Yeung, J.L.L. Teng, L. Jia, C. Zhang, C. Huang, J.-P. Cai et al. Soluble ACE-2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell 184(8), 2212\u20132228.e12 (2021). https:\/\/doi.org\/10.1016\/j.cell.2021.02.053","journal-title":"Cell"},{"issue":"4","key":"3331_CR76","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/diagnostics12040886","volume":"12","author":"N D\u00edaz-Troyano","year":"2022","unstructured":"N. D\u00edaz-Troyano, P. Gabriel-Medina, S. Weber et al. Soluble angiotensin-converting enzyme 2 as a prognostic biomarker for disease progression in patients infected with SARS-CoV-2. Diagnostics 12(4), 886 (2022). https:\/\/doi.org\/10.3390\/diagnostics12040886. Published 2022 Apr 1","journal-title":"Diagnostics"},{"key":"3331_CR77","doi-asserted-by":"publisher","first-page":"836516","DOI":"10.3389\/fimmu.2022.836516","volume":"13","author":"MDC Maza","year":"2022","unstructured":"M.D.C. Maza, M. \u00dabeda, P. Delgado et al. ACE-2 Serum Levels as Predictor of Infectability and Outcome in COVID-19. Front Immunol. 13, 836516 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.836516","journal-title":"Front Immunol."},{"key":"3331_CR78","doi-asserted-by":"publisher","unstructured":"V. Mariappan, P. Ranganadin, L. Shanmugam, S.R. Rao, A. Balakrishna Pillai, Early shedding of membrane-bounded ACE-2 could be an indicator for disease severity in SARS-CoV-2. Biochimie S0300-9084(22)00167-5 (2022). https:\/\/doi.org\/10.1016\/j.biochi.2022.06.005","DOI":"10.1016\/j.biochi.2022.06.005"},{"issue":"7","key":"3331_CR79","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/ph14070695","volume":"14","author":"AG Vassiliou","year":"2021","unstructured":"A.G. Vassiliou, A. Zacharis, C. Keskinidou et al. Soluble Angiotensin Converting Enzyme 2 (ACE-2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS). Pharmaceuticals 14(7), 695 (2021). https:\/\/doi.org\/10.3390\/ph14070695","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3331_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03141-9","volume":"24","author":"SA Kornilov","year":"2020","unstructured":"S.A. Kornilov, I. Lucas, K. Jade, C.L. Dai, J.C. Lovejoy, A.T. Magis, Plasma levels of soluble ACE-2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19. Crit. Care. 24(1), 452 (2020). https:\/\/doi.org\/10.1186\/s13054-020-03141-9","journal-title":"Crit. Care."},{"issue":"41","key":"3331_CR81","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1093\/eurheartj\/ehaa697","volume":"41","author":"L Wallentin","year":"2020","unstructured":"L. Wallentin, J. Lindb\u00e4ck, N. Eriksson et al. Angiotensin-converting enzyme 2 (ACE-2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur. Heart J. 41(41), 4037\u20134046 (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehaa697","journal-title":"Eur. Heart J."},{"issue":"9","key":"3331_CR82","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","volume":"203","author":"R Reindl-Schwaighofer","year":"2021","unstructured":"R. Reindl-Schwaighofer, S. H\u00f6dlmoser, F. Eskandary et al. ACE-2 Elevation in Severe COVID-19. Am. J. Respir. Crit. Care Med. 203(9), 1191\u20131196 (2021). https:\/\/doi.org\/10.1164\/rccm.202101-0142LE","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"3331_CR83","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/HJH.0000000000003054","volume":"40","author":"S Akin","year":"2022","unstructured":"S. Akin, P. Schriek, C. van Nieuwkoop et al. A low aldosterone\/renin ratio and high soluble ACE-2 associate with COVID-19 severity. J. Hypertens. 40(3), 606\u2013614 (2022). https:\/\/doi.org\/10.1097\/HJH.0000000000003054","journal-title":"J. Hypertens."},{"issue":"6","key":"3331_CR84","doi-asserted-by":"publisher","first-page":"e0252799","DOI":"10.1371\/journal.pone.0252799","volume":"16","author":"TW Kragstrup","year":"2021","unstructured":"T.W. Kragstrup, H.S. Singh, I. Grundberg et al. Plasma ACE-2 predicts outcome of COVID-19 in hospitalized patients. PLoS ONE 16(6), e0252799 (2021). https:\/\/doi.org\/10.1371\/journal.pone.0252799","journal-title":"PLoS ONE"},{"issue":"10","key":"3331_CR85","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1002\/jmv.27144","volume":"93","author":"A Lundstr\u00f6m","year":"2021","unstructured":"A. Lundstr\u00f6m, L. Ziegler, S. Havervall et al. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers. J. Med. Virol. 93(10), 5908\u20135916 (2021). https:\/\/doi.org\/10.1002\/jmv.27144","journal-title":"J. Med. Virol."},{"key":"3331_CR86","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","volume":"396","author":"S Narula","year":"2020","unstructured":"S. Narula, S. Yusuf, M. Chong, C. Ramasundarahettige, S. Rangarajan, S.I. Bangdiwala, M. van Eikels, K. Leineweber, A. Wu, M. Pigeyre, G. Par\u00e9, Plasma ACE-2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet 396, 968\u2013976 (2020). https:\/\/doi.org\/10.1016\/S0140-6736(20)31964-4","journal-title":"Lancet"},{"key":"3331_CR87","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","volume":"46","author":"H Jia","year":"2016","unstructured":"H. Jia, Pulmonary angiotensin-converting enzyme 2 (ACE-2) and inflammatory lung disease. Shock 46, 239\u2013248 (2016). https:\/\/doi.org\/10.1097\/SHK.0000000000000633","journal-title":"Shock"},{"key":"3331_CR88","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","volume":"13","author":"J Ramchand","year":"2020","unstructured":"J. Ramchand, S.K. Patel, L.G. Kearney, G. Matalanis, O. Farouque, P.M. Srivastava, L.M. Burrell, Plasma ACE-2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis. JACC Cardiovase Image 13, 655\u2013664 (2020). https:\/\/doi.org\/10.1016\/j.jcmg.2019.09.005","journal-title":"JACC Cardiovase Image"},{"issue":"8","key":"3331_CR89","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41574-021-00516-y","volume":"17","author":"L di Filippo","year":"2021","unstructured":"L. di Filippo, S. Frara, A. Giustina, The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat. Rev. Endocrinol. 17(8), 445\u2013446 (2021). https:\/\/doi.org\/10.1038\/s41574-021-00516-y","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"3331_CR90","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12020-022-03135-3","volume":"78","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, S. Frara, M. Doga, A. Giustina, The osteo-metabolic phenotype of COVID-19: an update. Endocrine 78(2), 247\u2013254 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03135-3","journal-title":"Endocrine"},{"issue":"3","key":"3331_CR91","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12020-020-02525-9","volume":"70","author":"L di Filippo","year":"2020","unstructured":"L. di Filippo, A.M. Formenti, A. Giustina, Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19. Endocrine 70(3), 463\u2013464 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02525-9","journal-title":"Endocrine"},{"issue":"2","key":"3331_CR92","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11154-021-09655-z","volume":"23","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, M. Doga, S. Frara, A. Giustina, Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications. Rev. Endocr. Metab. Disord. 23(2), 299\u2013308 (2022). https:\/\/doi.org\/10.1007\/s11154-021-09655-z","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"3331_CR93","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12020-021-02882-z","volume":"74","author":"L di Filippo","year":"2021","unstructured":"L. di Filippo, A. Allora, M. Locatelli et al. Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response. Endocrine 74(2), 219\u2013225 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02882-z","journal-title":"Endocrine"},{"key":"3331_CR94","doi-asserted-by":"publisher","first-page":"n1088","DOI":"10.1136\/bmj.n1088","volume":"373","author":"J Lopez Bernal","year":"2021","unstructured":"J. Lopez Bernal, N. Andrews, C. Gower et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ 373, n1088 (2021). https:\/\/doi.org\/10.1136\/bmj.n1088","journal-title":"BMJ"},{"issue":"10287","key":"3331_CR95","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","volume":"397","author":"EJ Haas","year":"2021","unstructured":"E.J. Haas, F.J. Angulo, J.M. McLaughlin et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data [published correction appears in Lancet. 2021 Jul 17;398(10296):212]. Lancet 397(10287), 1819\u20131829 (2021). https:\/\/doi.org\/10.1016\/S0140-6736(21)00947-8","journal-title":"Lancet"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03331-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T07:21:59Z","timestamp":1684567319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03331-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":95,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["3331"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03331-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"F.N. is an employee of Abiogen Pharma S.p.A. A.G. is consultant for Abiogen and Takeda and received research grant to Institution from Takeda. All other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol complies with the Declaration of Helsinki, was approved by the Hospital Ethics Committee (protocol ABIO\/NC\/03 no. 367\/2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}